These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22310912)

  • 1. Down-regulated expression of hsa-miR-181c in Fanconi anemia patients: implications in TNFα regulation and proliferation of hematopoietic progenitor cells.
    Río P; Agirre X; Garate L; Baños R; Álvarez L; San José-Enériz E; Badell I; Casado JA; Garín M; Prósper F; Bueren JA
    Blood; 2012 Mar; 119(13):3042-9. PubMed ID: 22310912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global miRNA expression of bone marrow mesenchymal stem/stromal cells derived from Fanconi anemia patients.
    Cagnan I; Keles M; Keskus AG; Tombaz M; Sahan OB; Aerts-Kaya F; Uckan-Cetinkaya D; Konu O; Gunel-Ozcan A
    Hum Cell; 2022 Jan; 35(1):111-124. PubMed ID: 34792755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of hsa-miR-6086 protects human umbilical vein endothelial cells against TNFα-induced proliferation inhibition and apoptosis via CDH5.
    Cai X; Zhou X; Xiao F; Ye B; Huang W; Huang Z
    Gene; 2018 Jun; 661():202-208. PubMed ID: 29605606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-β1 Production.
    Cagnan I; Gunel-Ozcan A; Aerts-Kaya F; Ameziane N; Kuskonmaz B; Dorsman J; Gumruk F; Uckan D
    Stem Cell Rev Rep; 2018 Jun; 14(3):425-437. PubMed ID: 29247345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fancb deficiency impairs hematopoietic stem cell function.
    Du W; Amarachintha S; Erden O; Wilson A; Meetei AR; Andreassen PR; Namekawa SH; Pang Q
    Sci Rep; 2015 Dec; 5():18127. PubMed ID: 26658157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy restores the transcriptional program of hematopoietic stem cells in Fanconi anemia.
    Lasaga M; Río P; Vilas-Zornoza A; Planell N; Navarro S; Alignani D; Fernández-Varas B; Mouzo D; Zubicaray J; Pujol RM; Nicoletti E; Schwartz JD; Sevilla J; Ainciburi M; Ullate-Agote A; Surrallés J; Perona R; Sastre L; Prosper F; Gomez-Cabrero D; Bueren JA
    Haematologica; 2023 Oct; 108(10):2652-2663. PubMed ID: 37021532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-181c targets Bcl-2 and regulates mitochondrial morphology in myocardial cells.
    Wang H; Li J; Chi H; Zhang F; Zhu X; Cai J; Yang X
    J Cell Mol Med; 2015 Sep; 19(9):2084-97. PubMed ID: 25898913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin-induced, TNFR-dependent miR-181c downregulation promotes MLL1 and NF-κB target gene expression in human microglia.
    Yin M; Chen Z; Ouyang Y; Zhang H; Wan Z; Wang H; Wu W; Yin X
    J Neuroinflammation; 2017 Jun; 14(1):132. PubMed ID: 28662718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha and CD95 ligation suppress erythropoiesis in Fanconi anemia C gene knockout mice.
    Otsuki T; Nagakura S; Wang J; Bloom M; Grompe M; Liu JM
    J Cell Physiol; 1999 Apr; 179(1):79-86. PubMed ID: 10082135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC).
    Liu JM; Kim S; Read EJ; Futaki M; Dokal I; Carter CS; Leitman SF; Pensiero M; Young NS; Walsh CE
    Hum Gene Ther; 1999 Sep; 10(14):2337-46. PubMed ID: 10515453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of basal microRNAs' patterns in human dental pulp stem cells.
    Vasanthan P; Govindasamy V; Gnanasegaran N; Kunasekaran W; Musa S; Abu Kasim NH
    J Cell Mol Med; 2015 Mar; 19(3):566-80. PubMed ID: 25475098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.
    Walsh CE; Nienhuis AW; Samulski RJ; Brown MG; Miller JL; Young NS; Liu JM
    J Clin Invest; 1994 Oct; 94(4):1440-8. PubMed ID: 7929819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced Analysis and Validation of a microRNA Signature for Fanconi Anemia.
    Cappelli E; Ravera S; Bertola N; Grilli F; Squillario M; Regis S; Degan P
    Genes (Basel); 2024 Jun; 15(7):. PubMed ID: 39062599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulation of hsa-miR-20b expression in TNF-α-induced premature senescence of human pulmonary microvascular endothelial cells.
    Wong PF; Jamal J; Tong KL; Khor ES; Yeap CE; Jong HL; Lee ST; Mustafa MR; Abubakar S
    Microvasc Res; 2017 Nov; 114():26-33. PubMed ID: 28595801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simplified approach to improve the efficiency and safety of ex vivo hematopoietic gene therapy in fanconi anemia patients.
    Jacome A; Navarro S; Casado JA; Rio P; Madero L; Estella J; Sevilla J; Badell I; Ortega JJ; Olivé T; Hanenberg H; Segovia JC; Bueren JA
    Hum Gene Ther; 2006 Feb; 17(2):245-50. PubMed ID: 16454658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory ROS promote and cooperate with the Fanconi anemia mutation for hematopoietic senescence.
    Zhang X; Sejas DP; Qiu Y; Williams DA; Pang Q
    J Cell Sci; 2007 May; 120(Pt 9):1572-83. PubMed ID: 17405815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency.
    Verhoeyen E; Roman-Rodriguez FJ; Cosset FL; Levy C; Rio P
    Curr Gene Ther; 2017; 16(5):297-308. PubMed ID: 28067165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentiviral-mediated genetic correction of hematopoietic and mesenchymal progenitor cells from Fanconi anemia patients.
    Jacome A; Navarro S; Río P; Yañez RM; González-Murillo A; Lozano ML; Lamana ML; Sevilla J; Olive T; Diaz-Heredia C; Badell I; Estella J; Madero L; Guenechea G; Casado J; Segovia JC; Bueren JA
    Mol Ther; 2009 Jun; 17(6):1083-92. PubMed ID: 19277017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxymetholone therapy of fanconi anemia suppresses osteopontin transcription and induces hematopoietic stem cell cycling.
    Zhang QS; Benedetti E; Deater M; Schubert K; Major A; Pelz C; Impey S; Marquez-Loza L; Rathbun RK; Kato S; Bagby GC; Grompe M
    Stem Cell Reports; 2015 Jan; 4(1):90-102. PubMed ID: 25434823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.